Aeglea BioTherapeutics, Inc. Bonus & Incentive Agreements
13 Contracts & Agreements
- Form of Stock Option Agreement under the Amended and Restated Spyre Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 7, 2024)
- Spyre Therapeutics, Inc. 2023 Equity Incentive Plan (Filed With SEC on December 22, 2023)
- Spyre Therapeutics, Inc. 2016 Equity Incentive Plan, As Amended and Restated Effective November 21, 2023 (Filed With SEC on December 22, 2023)
- 2015 Equity Incentive Plan and forms of award agreements (Filed With SEC on December 22, 2023)
- Amended and Restated Spyre 2023 Equity Incentive Plan (Filed With SEC on November 15, 2023)
- First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 15, 2023)
- 2016 Equity Incentive Plan and forms of award agreements, as amended (Filed With SEC on November 15, 2023)
- 2015 Equity Incentive Plan and forms of award agreements (Filed With SEC on November 15, 2023)
- Amended and Restated Spyre 2023 Equity Incentive Plan (Filed With SEC on August 11, 2023)
- First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 11, 2023)
- Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on November 8, 2018)
- AEGLEA BIOTHERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on March 28, 2016)
- AEGLEA BIOTHERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN As Adopted on March 10, 2015 (Filed With SEC on June 16, 2015)
